← Leaderboards
Michael Van Ameringen
Mcmaster University
$1,040,764
Attributed
$1,040,764
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $215.9K · FY2005–09$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,040,764 · 1
By mechanism
R01$1,040,764 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “High Prevalence”
- John M Lachin · George Washington University$125,907,614
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Gita Ramjee · Medical Research Council Of South Africa$89,161,330
- Taha E Taha · Johns Hopkins University$84,384,929
- Peter J O'Dwyer · University Of Pennsylvania$79,756,433
- Joseph B. Margolick · Johns Hopkins University$60,448,867
Research focus
High PrevalenceAffectGenesAreaAnxietyBenzodiazepinesAnxiety DisordersFunctional DisorderCharacteristicsClassificationClinicBaseClonazepamCommunitiesComorbidityCaliforniaCatecholaminesAntidepressive AgentsDistressDouble-Blind MethodEnsureEvaluationFaceMassachusetts
Grant awards (5)
Improving Outcomes in Pharmacotherapy of Social Phobia$204,686
R01 · FY2009 · MH · contact PI
Improving Outcomes in Pharmacotherapy of Social Phobia$204,688
R01 · FY2008 · MH · contact PI
Improving Outcomes in Pharmacotherapy of Social Phobia$204,686
R01 · FY2007 · MH · contact PI
Improving Outcomes in Pharmacotheraphy of Social Phobia$210,799
R01 · FY2006 · MH · contact PI
Improving Outcomes in Pharmacotheraphy of Social Phobia$215,905
R01 · FY2005 · MH